Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

EVG

Evgen Pharma (EVG)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
13/02/202017:17Alliance NewsAlliance NewsEvgen Pharma, Rochester University To Advance SFX-01 For TrialLSE:EVGEvgen Pharma Plc
13/02/202008:01UK RegulatoryEvgen Pharma PLC University of Rochester CollaborationLSE:EVGEvgen Pharma Plc
06/02/202014:45Alliance NewsAlliance NewsEvgen Pharma Hails "Positive" Data From Breast Cancer Drug ResearchLSE:EVGEvgen Pharma Plc
06/02/202008:00UK RegulatoryEvgen Pharma PLC University of Manchester collaboration discoveryLSE:EVGEvgen Pharma Plc
29/01/202015:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
29/01/202015:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
20/01/202016:39UK RegulatoryEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
17/12/201912:28Alliance NewsAlliance NewsEvgen Pharma Outlook Confident Amid Clinical Success And Trimmed LossLSE:EVGEvgen Pharma Plc
17/12/201908:01RNS Non-RegulatoryEvgen Pharma PLC Investor presentationLSE:EVGEvgen Pharma Plc
17/12/201908:00UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
05/12/201916:19Alliance NewsAlliance NewsEvgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 TrialsLSE:EVGEvgen Pharma Plc
05/12/201908:00UK RegulatoryEvgen Pharma PLC MOU with The University of DundeeLSE:EVGEvgen Pharma Plc
04/12/201916:11UK RegulatoryEvgen Pharma PLC Notice of ResultsLSE:EVGEvgen Pharma Plc
11/11/201913:23Alliance NewsAlliance NewsUPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid DevelopmentLSE:EVGEvgen Pharma Plc
11/11/201913:11UK RegulatoryEvgen Pharma PLC SAS study clarificationLSE:EVGEvgen Pharma Plc
11/11/201910:11Alliance NewsAlliance NewsEvgen Pharma Shares Drop On "Disappointing" SFX-01 Trial ResultsLSE:EVGEvgen Pharma Plc
11/11/201908:00UK RegulatoryEvgen Pharma PLC SFX-01 results in SAS studyLSE:EVGEvgen Pharma Plc
30/09/201908:00UK RegulatoryEvgen Pharma PLC ESMO presentation of Phase II STEM clinical dataLSE:EVGEvgen Pharma Plc
23/09/201914:09Alliance NewsAlliance NewsEvgen Pharma "Delighted" With Extended Breast Cancer Treatment ResultsLSE:EVGEvgen Pharma Plc
23/09/201908:00UK RegulatoryEvgen Pharma PLC Update on extended-use phase of STEM trialLSE:EVGEvgen Pharma Plc
05/09/201914:39Alliance NewsAlliance NewsEvgen Pharma To Supply Lead Candidate SFX-01 In Possible Autism TrialLSE:EVGEvgen Pharma Plc
05/09/201908:00UK RegulatoryEvgen Pharma PLC Agreement for supply of SFX-01 for autism trialLSE:EVGEvgen Pharma Plc
28/08/201913:06Alliance NewsAlliance NewsEvgen Pharma Receives Last Patient For Stroke Treatment Drug TrialLSE:EVGEvgen Pharma Plc
28/08/201908:00UK RegulatoryEvgen Pharma PLC Update on SAS studyLSE:EVGEvgen Pharma Plc
07/08/201912:47Alliance NewsAlliance NewsEvgen Pharma Gets European Patent Covering Composition Of SFX-01LSE:EVGEvgen Pharma Plc
07/08/201908:00UK RegulatoryEvgen Pharma PLC Grant of further European patentLSE:EVGEvgen Pharma Plc
05/08/201912:45Alliance NewsAlliance NewsEvgen Pharma To Collaborate With King's College And British HeartLSE:EVGEvgen Pharma Plc
05/08/201908:00RNS Non-RegulatoryEvgen Pharma PLC Research collaborationLSE:EVGEvgen Pharma Plc
25/07/201914:00UK RegulatoryEvgen Pharma PLC Grant of OptionsLSE:EVGEvgen Pharma Plc
18/07/201916:47UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network